Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clinical and experimental dermatology [Clin Exp Dermatol] NLMUID: 7606847"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 247
Tytuł:
#corticophobia: a review on online misinformation related to topical steroids.
Autorzy:
Finnegan P; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Murphy M; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.
O'Connor C; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Feb 02; Vol. 48 (2), pp. 112-115.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Skin Diseases*/drug therapy
Dermatologic Agents*/therapeutic use
Humans ; Adrenal Cortex Hormones/adverse effects ; Glucocorticoids ; Steroids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.
Autorzy:
Moledina Z; Department of Dermatology, Nottingham University Hospitals NHS Trust, UK.
McPhee M; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.
Ravenscroft JC; Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, UK.
Healy E; Department of Dermatopharmacology, Faculty of Medicine, University of Southampton, UK.
Radley K; Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, UK.
Thomas KS; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.
Burden-Teh E; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.
Pokaż więcej
Corporate Authors:
Acne-ID Trial Development Team
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Jan 20; Vol. 48 (1), pp. 20-23.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/therapeutic use
Dermatology*
Acne Vulgaris*/drug therapy
Humans ; Isotretinoin/therapeutic use ; Treatment Outcome ; Administration, Oral ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regular support provided by dermatological nurses improves outcomes in patients with psoriasis treated with topical drugs: a randomized controlled trial.
Autorzy:
Svendsen MT; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense University Hospital, Denmark.; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Feldman SR; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense University Hospital, Denmark.; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Mejldal A; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Möller S; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Kongstad LP; Danish Centre for Health Economics (DaCHE), University of Southern Denmark, Odense, Denmark.
Andersen KE; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Dec; Vol. 47 (12), pp. 2208-2221. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Humans ; Patient Compliance ; Quality of Life ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acupuncture and osteopathic medicine for atopic dermatitis: a three-armed, randomized controlled explorative clinical trial.
Autorzy:
Rotter G; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ahnert MW; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Geue AV; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Icke K; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Binting S; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Tissen-Diabaté T; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Roll S; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ortiz M; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Reinhold T; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Kass B; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Staab D; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Pfab F; Medzentrum Residenz, Munich, Germany.
Willich SN; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brinkhaus B; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Dec; Vol. 47 (12), pp. 2166-2175. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Osteopathic Medicine*
Dermatologic Agents*/therapeutic use
Acupuncture Therapy*
Male ; Adult ; Humans ; Female ; Young Adult ; Treatment Outcome ; Pruritus/therapy ; Pruritus/chemically induced ; Severity of Illness Index ; Adrenal Cortex Hormones/therapeutic use ; Double-Blind Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.
Autorzy:
Leighton P; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Chalmers JR; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Batchelor JM; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Rogers A; Department of Medical Physics and Clinical Engineering, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Akram P; Department of Medical Physics and Clinical Engineering, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Haines RH; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
Meakin GD; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
White J; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
Ravenscroft JC; Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Sach TH; Norwich Medical School, University of East Anglia, Norwich, UK.
Santer M; Primary Care and Population Sciences, University of Southampton, Southampton, UK.
Whitton ME; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Eleftheriadou V; Walsall Manor Hospital, Walsall, UK.
Thomas KS; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Aug; Vol. 47 (8), pp. 1480-1489. Date of Electronic Publication: 2022 May 30.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Dermatologic Agents*/therapeutic use
Ultraviolet Therapy*/methods
Vitiligo*/drug therapy
Humans ; Surveys and Questionnaires ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical steroid withdrawal through the lens of social media.
Autorzy:
Bowe S; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Masterson S; Medical School, University of Limerick, Limerick, Ireland.
Murray G; Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
Haugh I; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Aug; Vol. 47 (8), pp. 1554-1557. Date of Electronic Publication: 2022 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Eczema*/chemically induced
Social Media*
Glucocorticoids/adverse effects ; Humans ; Retrospective Studies ; Steroids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.
Autorzy:
Azizzadeh M; Clinical Research Development Unit (CRDU), Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran.
Pahlevan D; Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Bagheri B; Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 May; Vol. 47 (5), pp. 926-931. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Dermatitis, Seborrheic*/drug therapy
Dermatologic Agents*/therapeutic use
Double-Blind Method ; Emollients/therapeutic use ; Humans ; Imidazoles ; Tacrolimus/adverse effects ; Tacrolimus/analogs & derivatives ; Thiophenes ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36-month follow-up study.
Autorzy:
Salava A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Perälä M; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Pelkonen A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Mäkelä M; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Remitz A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 May; Vol. 47 (5), pp. 889-902. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Dermatitis, Atopic*/pathology
Dermatologic Agents*/therapeutic use
Administration, Topical ; Child ; Child, Preschool ; Follow-Up Studies ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/adverse effects ; Infant ; Ointments/therapeutic use ; Tacrolimus/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin: a pilot study of an active monitoring of depressive disorders by dermatologists.
Autorzy:
Hefez L; Department of Dermatology, Grand Hôpital Est Francilien, Jossigny, France.
Micallef J; Service de Pharmacologie Clinique et Pharmacovigilance, Pharmacometry and Pharmacoepidemiology, Institut de Neurosciences des Systèmes, APHM/INSERM/Aix Marseille University, Marseille, France.
Revah-Levy A; Department of Adolescent Psychiatry, Centre Hospitalier Victor Dupouy, Argenteuil, France.; ECSTRRA team, Statistic And Epidemiological Research Centre Sorbonne Paris Cité (CRESS), INSERM U1153, Université de Paris, Paris, France.
Falissard B; INSERM U669, Paris-Sud 11 University, APHP, Villejuif, France, Paris, France.
Jouve E; Service de Pharmacologie Clinique et Pharmacovigilance, Pharmacometry and Pharmacoepidemiology, Institut de Neurosciences des Systèmes, APHM/INSERM/Aix Marseille University, Marseille, France.
Dreno B; Onco-Dermatology Department, CHU Nantes, CRCINA, Nantes University, Nantes, France.
Chosidow O; Department of Dermatology, APHP, Hôpital Henri-Mondor, Faculté de Santé, Paris-Est, Créteil, France.; Research Group Dynamic, EA7380, Faculté de Santé de Créteil, École Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est Créteil, Créteil, France.; Centre de Preuves de la Société Française de Dermatologie, Paris, France.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Apr; Vol. 47 (4), pp. 709-716. Date of Electronic Publication: 2021 Dec 27.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Acne Vulgaris*/drug therapy
Acne Vulgaris*/psychology
Depressive Disorder*/diagnosis
Depressive Disorder*/drug therapy
Depressive Disorder*/etiology
Dermatologic Agents*/adverse effects
Dermatologic Agents*/therapeutic use
Adolescent ; Depression/diagnosis ; Depression/drug therapy ; Depression/etiology ; Dermatologists ; Humans ; Isotretinoin/adverse effects ; Isotretinoin/therapeutic use ; Pilot Projects ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cysteamine as a topical management option for melasma.
Autorzy:
Hira SK; Department of Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Nalluri R; Department of Dermatology, Manchester University NHS Foundation Trust Varna pigmentation, Manchester, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 646-647. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cysteamine/*administration & dosage
Dermatologic Agents/*administration & dosage
Melanosis/*drug therapy
Administration, Topical ; Humans ; Intention to Treat Analysis ; Skin Cream ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.
Autorzy:
Zengarini C; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Roda M; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Schiavi C; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Bruni F; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Bardazzi F; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Bellusci C; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Raone B; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 604-606. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Anti-Allergic Agents/*therapeutic use
Dermatitis, Atopic/*complications
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*therapeutic use
Keratoconjunctivitis/*complications
Keratoconjunctivitis/*drug therapy
Omalizumab/*therapeutic use
Adolescent ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/pathology ; Hand Dermatoses/complications ; Hand Dermatoses/drug therapy ; Hand Dermatoses/immunology ; Humans ; Immunoglobulin E/blood ; Keratoconjunctivitis/immunology ; Keratoconjunctivitis/pathology ; Male
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.
Autorzy:
Raimondo A; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Guglielmi G; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Marino C; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Ligrone L; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Lembo S; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 592-593. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Antibodies, Monoclonal, Humanized/*adverse effects
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*adverse effects
Osteoarthritis, Spine/*chemically induced
Adult ; Azetidines/therapeutic use ; Dermatologic Agents/therapeutic use ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 2/antagonists & inhibitors ; Male ; Osteoarthritis, Spine/diagnosis ; Osteoarthritis, Spine/drug therapy ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Sulfonamides/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris.
Autorzy:
Kirchner A; University of Illinois College of Medicine, Chicago, IL, USA.
Hoyer S; Department of Dermatology, University of Illinois College of Medicine, Chicago, IL, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 619-621. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Abnormalities, Multiple/*drug therapy
Darier Disease/*drug therapy
Dermatologic Agents/*therapeutic use
Eyebrows/*abnormalities
Isotretinoin/*therapeutic use
Abnormalities, Multiple/pathology ; Adolescent ; Darier Disease/pathology ; Dermatologic Agents/administration & dosage ; Drug Administration Schedule ; Eyebrows/pathology ; Female ; Humans ; Isotretinoin/administration & dosage ; Treatment Outcome
SCR Disease Name:
Burnett Schwartz Berberian syndrome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double-blind, active- and placebo-controlled study.
Autorzy:
Mohammed GF; Department of Dermatology, Venereology and Sexology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 534-541. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Axilla*/pathology
Cyperus*
Anti-Inflammatory Agents/*therapeutic use
Dermatologic Agents/*therapeutic use
Hyperpigmentation/*drug therapy
Oils, Volatile/*therapeutic use
Administration, Topical ; Adult ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/economics ; Colorimetry ; Cost-Benefit Analysis ; Dermatologic Agents/adverse effects ; Dermatologic Agents/economics ; Double-Blind Method ; Female ; Hair/drug effects ; Hair/growth & development ; Humans ; Hydroquinones/therapeutic use ; Hyperpigmentation/pathology ; Oils, Volatile/adverse effects ; Oils, Volatile/economics ; Skin Cream ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risankizumab-induced paradoxical pustular psoriasis.
Autorzy:
McFeely O; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Pender E; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Victory L; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Almutlaq H; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.; Department of Dermatology, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Storan E; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 616-617. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Antibodies, Monoclonal/*adverse effects
Dermatologic Agents/*adverse effects
Interleukin-23 Subunit p19/*antagonists & inhibitors
Psoriasis/*chemically induced
Cyclosporine/therapeutic use ; Dermatologic Agents/therapeutic use ; Disease Progression ; Female ; Humans ; Middle Aged ; Psoriasis/drug therapy ; Psoriasis/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.
Autorzy:
Ruggiero A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Cinelli E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Ocampo Garza SS; Department of Dermatology, University Hospital Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Camela E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 561-567. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Biological Products/*therapeutic use
Dermatologic Agents/*therapeutic use
Interleukin-23 Subunit p19/*antagonists & inhibitors
Psoriasis/*drug therapy
Age of Onset ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Biological Products/adverse effects ; Dermatologic Agents/adverse effects ; Female ; Humans ; Male ; Psoriasis/immunology ; Remission Induction ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful use of tofacitinib in epidermolysis bullosa pruriginosa.
Autorzy:
Chen KJ; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Fang S; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ye Q; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jia M; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 598-600. Date of Electronic Publication: 2021 Nov 28.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Dermatologic Agents/*therapeutic use
Epidermolysis Bullosa Dystrophica/*drug therapy
Janus Kinase Inhibitors/*therapeutic use
Piperidines/*therapeutic use
Pyrimidines/*therapeutic use
Adult ; Epidermolysis Bullosa Dystrophica/complications ; Epidermolysis Bullosa Dystrophica/pathology ; Female ; Humans ; Pruritus/drug therapy ; Pruritus/etiology
SCR Disease Name:
Epidermolysis Bullosa Pruriginosa
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Racial representation in clinical trials for dermatological new molecular entities.
Autorzy:
Ha MV; Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Wong C; Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Feb; Vol. 47 (2), pp. 386-388. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Dermatologic Agents*
Patient Selection*
Black or African American/*statistics & numerical data
Drug Approval/*statistics & numerical data
Dermatology ; Ethnic and Racial Minorities/statistics & numerical data ; Humans ; Skin Diseases/drug therapy ; Skin Diseases/ethnology ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful use of dupilumab for the treatment of atopic dermatitis on the genitals, a neglected anatomical site.
Autorzy:
Paolino G; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Sernicola A; Dermatology Clinic, Sapienza University of Rome, Rome, Italy.
Di Nicola MR; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Foti A; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Brianti P; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Vaira F; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Grieco T; Dermatology Clinic, Sapienza University of Rome, Rome, Italy.
Mercuri SR; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 176-178. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Letter
MeSH Terms:
Antibodies, Monoclonal, Humanized/*therapeutic use
Dermatitis, Atopic/*drug therapy
Dermatitis, Atopic/*pathology
Dermatologic Agents/*therapeutic use
Genitalia, Female/*pathology
Genitalia, Male/*pathology
Interleukin-4 Receptor alpha Subunit/*antagonists & inhibitors
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Topical treatment samples: plastic, recycling and sustainability.
Autorzy:
Kamp E; Dermatology Department, University Hospitals Sussex, Brighton, UK.
Musbahi E; Dermatology Department, University Hospitals Sussex, Brighton, UK.
Gupta P; Dermatology Department, University Hospitals Sussex, Brighton, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 186. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji:
Letter
MeSH Terms:
Conservation of Natural Resources*
Dermatologic Agents*
Drug Packaging*
Plastics*
Recycling*
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 247

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies